JANX
JANX
US47103J1051
Janux Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.12B EUR
938.16M EUR
846.03M EUR
833.3M EUR
Enterprise Value
181.11M EUR
931.38M EUR
815.77M EUR
803.11M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-7.01x
--
--
--
Price to Sales
46.85x
39.09x
61.61x
83.33x
Price to Book
1.21x
1.01x
0.9x
0.87x
EV/Revenue
7.55x
38.81x
59.4x
80.31x
EV/EBITDA
-1.28x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.46%
-4.47%
-9.28%
-7.91%
ende